About This Statistic
This statistic displays the top ten oncology products worldwide in 2015, ranked by revenue. The list was headed by Rituxan, a cancer drug manufactured by Swiss-based company Roche. Rituxan is used for the treatment for common forms of blood cancer, including non-Hodgkin's lymphoma (NHL), follicular lymphoma and chronic lymphocytic leukaemia (CLL), but it can also be used to treat rheumatoid arthritis and certain types of vasculitis. In that year, three of Roche's products were among the top 10 cancer drugs worldwide.